FDA Brief

Warning letters Drugs

FDA warning letter to

Limpo Quimicos, SA de CV

High riskIssued Sep 30, 2021Posted Oct 5, 2021Center for Drug Evaluation and Research | CDER

Limpo Quimicos' hand sanitizers were refused at the U.S. border after FDA found methanol substitution and low ethanol.

What happened

FDA tested batches of Andy’s Best ADVANCED HAND SANITIZER and NeoNatural gel Hand Sanitizer after they were detained and refused admission at the U.S. border. Andy’s Best was labeled 70% ethanol but batches averaged about 1% ethanol and 63–66% methanol; NeoNatural was labeled 70% ethanol but one batch averaged 32% ethanol. FDA also cited manufacturing quality, unapproved new drug, and labeling violations and said the firm had not taken market action on all products.

What FDA found

  1. Andy’s Best ADVANCED HAND SANITIZER was labeled to contain 70% ethanol, but FDA testing found about 1% ethanol and 63–66% methanol, meaning ethanol was replaced with a dangerous chemical.

    FD&C Act section 501(d)(2), 21 U.S.C. 351(d)(2)
  2. NeoNatural gel Hand Sanitizer was labeled to contain 70% ethanol, but FDA testing found an average of only 32% ethanol.

    FD&C Act section 501(c), 21 U.S.C. 351(c)
  3. The substitution and low strength showed that the firm’s quality assurance was not working under current good manufacturing practice (CGMP), the rules for making drugs consistently and safely.

    FD&C Act section 501(a)(2)(B), 21 U.S.C. 351(a)(2)(B)
  4. Both hand sanitizers were marketed as new drugs without FDA approval and did not meet the conditions for over-the-counter marketing without approval.

    FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)
  5. Andy’s Best was misbranded (illegally labeled) because its label was false or misleading, it was dangerous when used as labeled, and it did not declare methanol.

    FD&C Act sections 502(j), (a), (e), and (ee), 21 U.S.C. 352(j), (a), (e), and (ee)
  6. NeoNatural gel Hand Sanitizer was misbranded because its label falsely stated 70% ethanol and it did not comply with the requirements for marketing under section 505G.

    FD&C Act sections 502(a) and (ee), 21 U.S.C. 352(a) and (ee)

What FDA wants

FDA tells Limpo Quimicos to respond in writing within 15 working days, including detailed investigations into the methanol substitution and low ethanol, a list of raw materials and suppliers, a list and reconciliation of U.S. shipments, and complete batch records. FDA also recommends a qualified CGMP consultant and a regulatory meeting if the firm wants to make drugs for the U.S. again.

Who should pay attention

  • distributors and retailers of hand sanitizers
  • brands buying hand sanitizer from contract manufacturers
  • consumers and organizations relying on labeled ethanol content

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. World Perfumes Inc.

    World Perfumes failed to test drug ingredients for toxic contaminants and had inadequate water, FDA says.

    High risk
  2. RNA Bio/Pharma, Incorporated

    FDA found RNA Bio/Pharma failed to test homeopathic oral liquid drugs for dangerous contaminants and did not validate its water system.

    High risk
  3. Kabana Skin Care LLC

    Kabana Skin Care failed to test OTC drug ingredients and finished products, prompting a recall and halt of U.S. drug manufacturing.

    High risk
  4. Ningbo Riway Industrial Co., Ltd.

    Ningbo Riway Industrial, an OTC drug maker in China, was cited for manufacturing-practice failures and unapproved antiseptic wipes.

    High risk